Post-licensure monitoring of HPV vaccine in the United States.

摘要: Post-licensure evaluation of vaccines plays an important role in monitoring the progress immunization programs, demonstrating population impact vaccines, and providing data for ongoing policy decisions. Two human papillomovirus (HPV) are licensed recommended use females United States, a quadrivalent HPV vaccine, 2006 bivalent vaccine 2009. vaccination is 11 or 12 years age with catch-up through 26 years. program has included some same systems established other such as those safety coverage monitoring. However, on infection disease outcomes required new efforts. While there well cancer registries it will take decades before cervical observed. More proximal measures include prevalence types, incidence precancers genital warts. We review place being post-licensure States.